Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polycaprolactone (PCL) and polylactic acid (PLA) human body absorbable vascular stent and preparation method thereof

A technology for vascular stents and the human body, applied in stents, medical science, surgery, etc., can solve problems such as low mechanical properties of stents, product changes, loss of developing atoms of ion-type developing resins, etc., to achieve easy observation and research, compatibility Good performance and controllable degradation cycle

Inactive Publication Date: 2011-04-06
DONGHUA UNIV
View PDF14 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the blending method easily leads to changes in the product, and it is easy to form an ionic developing resin, which is easy to absorb water and cause the loss of developing atoms [Xia Weijuan et al. A preparation method of developing polyurethane (200810223421.5)]
W.A.Chan added barium sulfate into polylactide as a contrast agent to prepare a stent with visual effects. After the stent is implanted in the body, it is easy to be tracked, but the mechanical properties of the stent prepared are lower than The mechanical properties of the stent prepared without adding contrast agent are lower [W.A.Chan, eal. Effect of radio-opaque filler on biodegradable stent Properties. Journal of Biomedical Materials Research Part A, 2005, 6(6): 47-52]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polycaprolactone (PCL) and polylactic acid (PLA) human body absorbable vascular stent and preparation method thereof
  • Polycaprolactone (PCL) and polylactic acid (PLA) human body absorbable vascular stent and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029]Weigh 500g samples according to the mass ratio PCL:PLA=1:4, extrude the nascent blended fibers in a twin-screw blending extruder at 190°C, and stretch the nascent blended fibers to obtain a diameter of 0.1mm. Oriented crystalline fiber; weigh barium sulfate and PCL raw materials according to the mass ratio of 1:2, and prepare hollow tubular joints by melt blending method; weave the blended stretched fiber into a network structure blood vessel with a length of 20mm and an inner diameter of 3mm For the stent, use barium sulfate and PCL hollow tubular joints to seal the fibers at both ends of the stent to obtain a mesh-like vascular stent with certain mechanical properties and high elasticity; heat-setting the stent at 95°C for 20 minutes, A blood vessel stent with X-ray display at both ends is obtained.

Embodiment 2

[0031] Weigh 500g samples according to the mass ratio PCL:PLA=2:3, extrude the nascent blended fibers in a twin-screw blending extruder at 170°C, and stretch the nascent blended fibers to obtain a diameter of 0.2mm. Oriented crystalline fiber; weigh barium sulfate and PCL raw materials according to the mass ratio of 1:3, and prepare hollow tubular joints by melt blending method; weave the blended stretched fiber into a network structure blood vessel with a length of 40mm and an inner diameter of 5mm For the stent, use barium sulfate and PCL hollow tubular joints to seal the fibers at both ends of the stent respectively to obtain a mesh-like vascular stent with certain mechanical properties and high elasticity; heat-setting the stent at 115°C for 25 minutes, A blood vessel stent with X-ray display at both ends is obtained.

Embodiment 3

[0033] Weigh 500g samples according to the mass ratio PCL:PLA=1:1, extrude the nascent blended fibers at 200°C in a twin-screw blending extruder, and stretch the nascent blended fibers to obtain a diameter of 0.3mm. Oriented crystalline fiber; weigh barium sulfate and PCL raw materials according to the mass ratio of 1:4, and prepare hollow tubular joints by melt blending method; weave the blended stretched fiber into a network structure blood vessel with a length of 60 mm and an inner diameter of 6 mm For the stent, use barium sulfate and PCL hollow tubular joints to seal the fibers at both ends of the stent respectively to obtain a mesh-like vascular stent with certain mechanical properties and high elasticity; heat-setting the stent at 135°C for 30 minutes, A blood vessel stent with X-ray display at both ends is obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to a polycaprolactone (PCL) and polylactic acid (PLA) human body absorbable vascular stent and a preparation method thereof. The two ends of a degradable vascular stent prepared from PCL and PLA fibers are provided with tracing joints with X-ray dominance. The preparation method comprises the following steps of: preparing PCL and PLA as-spun fibers by a melt blended spinning method and stretching the PCL and PLA as-spun fibers; and weaving the stretched fibers on a self-made vascular stent die, connecting the heads of the fibers by using barium sulfate and PCL hollow tubular joints, and performing heat setting on the stent to obtain the vascular stent of which the two ends have the X-ray dominance. The material of the stent has high compatibility with a human body, the prepared stent has stable performance, and the barium sulfate tubular joints at the two ends of the stent have the function of in-vivo X-ray tracing targets, so the stent is convenient to observe and research after being implanted into the human body; and the preparation method is simple and has low cost and good application prospect.

Description

technical field [0001] The invention belongs to the field of human body absorbable vascular stent and preparation thereof, in particular to a PCL and PLA human body absorbable vascular stent and a preparation method thereof. Background technique [0002] With the improvement of human living standards and changes in diet structure, the incidence of cardiovascular diseases is increasing. Coronary heart disease caused by cardiovascular stenosis has become a major disease that endangers people's health. Since the beginning of the 20th century, people have made unremitting efforts to treat coronary heart disease. From the initial relief of symptoms and relief of pain, it has gradually developed to radical surgery and interventional therapy with balloon stents. In recent years, surgical replacement or bypass grafting is the main means of treating coronary artery or peripheral atherosclerotic disease, and coronary artery stent implantation has been widely used in the treatment of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61F2/90A61L31/18A61L31/06A61L31/12
Inventor 杨庆时翠红赵婧郯志清沈新元张佩华
Owner DONGHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products